RABBIES VACCINE (INACTIVATED)
Features & Benefits
The strain of rabies virus CTN-1V is produced as the virus species. The homology of CTN strain and nucleotide of various strains in China is 82% to 93%, homology between which is greater than that of other vaccine strains, and more suitable for domestic use in China.
Adopt the world’s leading U.S. NBS bioreactor
Adopt the large-scale cultivation process of world’s leading U.S. NBS40L bioreactor , together with the easy-to-attach, high-yield polyester chip carrier (Fibra-Cel Disk), to achieve stability control on the entire cultivation process, and greatly reduced exogenous pollution risks.
Adopt No antibiotics-added during whole production process technology. Without residual antibiotics and side-effect problem, vaccination response incidence is greatly decreased.
Quality indices are better than national standards
Quality indices are better than national standards
| Standards | Titer | Bovine Serum Albumin |
| National pharmacopoeia standard | ≥2.5IU | ≤50ng/dose |
| Zhuoyi Bio registration standard | ≥4.0IU | ≤40ng/dose |
0.5ml/dose，more convenient and safer
Less side effect. Higher safety. Single dose package for convenient use.
| SKU | Thumbnail | Stock | SIZE | Quantity | ||
|---|---|---|---|---|---|---|
|
|
100 Left | BIOSHOOT 2.5 IU POWDER FOR INJECTION |
-
+
|
